Fortress Investment Group Core Competencies

Fortress Investment Group started as a pure private equity firm in the year 1998. However, the company extended its services to a wide range of activities including credit, real estate, and permanent capital investment policies. Wesley Edens, Randal and Rob Kauffman are the co-founders of this company. In the recent past, the company’s performance is commendable, and it is as a result of good leadership attributed by Wesley Edens and other principals. The company’s leadership aims at maintaining solid company governance practices and policies. Moreover, the Board of Directors has formulated a framework to ensure a high level of corporate accountability and integrity. As per December 2017 statistics, the company managed assets worth $43.6 billion.

One of the main contributions to Fortress investment Group success is its core competencies. First, the company specializes in asset-based investments hence it has a long time and broad experience. Additionally, the company’s expertise is also evident in pricing and financing of capital assets and real estate properties. Apart from proficiency in asset management, the company has adequate knowledge about the industries it invests. Indeed, the company has formed a group of investment specialists and developed good relationships with prominent institutions and individuals globally. Thirdly, fortress investment group is highly competent in its management operations because it has established tools to assess existing challenges. The company also ensures low-cost and fewer risks when financing its investments as a result of extensive expertise in capital markets. The capital market expertise enables the group to access debt as well as equity capital markets.

Fortress investment group has broad and extensive know-how in acquisitions and corporate merging. Acquisitions experience enables the corporate management to work and get along with various stakeholders. In February 2017, Softbank signed a treaty to acquire Fortress investment group for about cash of $ 3.3 billion. Under this merger treaty conditions, every Class A investor in Fortress would get $8.08 for each share which represented a first-class of 51.2% of Fortress’s 3-month volume-weighted typical price, but it excluded dividend. The senior investment professional remained and their significant contribution to fund performance. However, Fortress operates within Softbank as an independent whereby the three principals, Peter Briger, Randy Nardone and Wes Eden, will continue managing. The Softbank is responsible for sustaining the leadership, brand, personnel, business model, processes, and culture. Moreover, the Softbank has the mandate to get in partners and shareholders a given percentage of the venture.

May 13, 2018

Posted In: Finance Industry, Investor

Tags:

Ronald Fowlkes  Top Reasons Why Mentorship is So Important to Him

Those who retire from marine or SWAT team often want to spend time relaxing and enjoy their retirement years. They have been giving back to the community and want to continue doing the same once they have retired. Ronald Fowlkes has found a way to do just that while still being able to love what they do. He is one of the top leaders of FirstSpear. The company is in the business of providing tactical equipment to its clients who are mainly soldiers and peacekeepers. He has himself used such supplies while he was in service and it was during that time that he learned how the uniform makes one more efficient.

 

Ronald Fowlkes has used products from FirstSpear, and during that time he was impressed with the efficiency of the products. When he joined the Police Force, he used the same products there and loved it. Thus, when he was asked to join FirstSpear, he did not hesitate a bit and joined as the leader. His son is part of the St. Louis Blues Triple-A team, and Ronald Fowlkes is their off-ice trainer and also ensures that the team equipment is well taken care of. He also spends time teaching the kids about the importance to keep their gear in the best condition. He believes that the kids understand that the condition of the gear can make them lose a game or win one and it is the reason that they make extra effort to take care of their equipment.

 

Ronald Fowlkes worked for the Marines after completing his graduation from the Army Parachute School and then joined the Police Force. For him, it is not just about the uniform; he has utmost love and respect for the country that has allowed him to provide long service. Even after his retirement, he wants to serve the people of his country and to those who are trying to keep the country safe. It is the reason why training and being there for the next generation is crucial to him as an individual. He also helps the team with physical training to ensure that they are fit for the games. Since he has learned all about fitness during his life as a marine and police officer, he has been able to help the team win games.

 

Ronald Fowlkes shares his personal experiences with his son and his team. He believes that by doing so, he has been able to make the children realize that one should respect those who are putting themselves out there for other’s safety. By being a mentor for them, he has allowed children to open up to him and trust him with anything. Mentorship has allowed him to keep fit and also be a guide to the young minds.

 

 

May 11, 2018

Posted In: Business

Alexandre Gama – International Creative Sensation

Alexandre Gama

Alexandre Gama is the very first Brazilian man to lead the British-Based agency. He was granted title of Global Chief Creative Officer (WCCO) and the only Brazilian member of Publicis Groupe Global Creative Board. The six-member committee includes agency creative leaders in the global company.

Early Career

Alexandre Gama worked at several advertising companies. He began with Standard Ogilvy & Mather in 1982. He was both a creative and copywriter with the company.

Eight years later he moved to DM9. His career move garnered him heightened responsibility as copywriter and Creative Director. By the time Gama had moved to another company, Gama could brag that he was the most-awarded copywriter of his entire generation of Brazilian copywriters.

Gama also worked at Almap BBDO and was a shareholder with the company. He also worked as CEO of Young and Rubicam. In 1996, he joined the Global Board as CCO and member.

Entrepreneur

In 1999, Gama left Young and Rubicam to start Neogama. Shortly after, in 2008, Gama broke through another barrier to become the first Latin American to present a Master Class at Cannes in France.

In 2002, Gama associated Neogama to BBH, the London-based agency, creating Neogama/BBH though he maintained control by remaining the major shareholder.

In 2016, Gama and Neogama left the BBH network. Gama started a new phase focused on the agency’s roots in Brazil. He retook the name Neogama and operated independently. He also, in 2016, sold Neogama to Publicis Groupe.

Board of Directors

Gama became board member of Brazilian Association of Advertising Agencies and took on the responsibility of support and promotions of communications best-practices of Brazil.

Awards

Gama has received numerous awards since becoming a creative and copywriter. Both his personal accomplishments and his business accomplishments have been acknowledged internationally since 2006.

Neogama/BBH was named “Agency of the Year” by Meio e Mensagem periodical. It was the first Brazilian agency to win two Golden Lions in the same year in Cannes two main categories: Press and Film.

May 5, 2018

Posted In: Advertising Leader

Talkspace, De-stress With The Best

Talkspace is a company that involves the nurturance of peoples souls as their broken pieces are put back together at the efforts of a psychological analyst. These pieces can be hard to puzzle back together due to the heavy chains of stress one can endure on a daily and even hourly basis. These constraints have an effect on the body that many may turn a blind eye to.

The body can fill with stress hormones of cortisol and adrenaline which deplete the immune systems while causing the heart to work harder than it has to in order to excert blood throughout the bloodstream. This can trigger muscular discomfort as the hormones constrict the muscle tissues, therefore making them tighter than is necessary. This tension in the human muscular system can also cause rapid breathing, hyperventilation in the respiratory organs, and ultimately it can cause an onset of severe panic attacks in the stressed out sentient being. The purpose of stress in most cases is to enact the survival tactics interwoven in the lower forms of human consciousness located at the reptilian part of the brain.

However, since there is normally no consistent exposure to the volatile experiences in which the stress hormone would prove useful to the survival of the participant when a stressful situation does present itself, this can damage the bodily functions of the subject. Therefore since such an atrocity can harm a person and let’s say a person who does not feel comfortable talking in a physical office, what can be done about it.

The relevant suggestion is basic and precise, and that is to introduce the subject to Talkspace, where the people who work there are a group of dedicated and legitimate individuals who love and believe in what it is they do. Many workers in the business system also exclaim that they can sense a closer connection with their prospects than they would in a traditional office setting. A participant who conducts therapy on what it is that is causing the stress may find alleviation in their symptoms after all.

May 1, 2018

Posted In: Personality Disorder

Sahm Adrangi Is Taking The Short Side With Proteostasis With Latest Negative Report From Kerrisdale

Sahm Adrangi is a well-known man in the investing world thanks to his many accomplishments as an investor and his success at Kerrisdale Capital. This private investment firm invests in various companies around the world. Today, being able to identify quality companies in the stock market is a challenge, and Sahm Adrangi is standing out where not many can. Kerrisdale has managed to excel and come out on top of the S&P 500 for several successive quarters.

On a normal basis, Kerrisdale Capital puts out reports on various companies in the market, and their latest was quite the negative report against biotech firm Proteostasis. This biotech company is home to Cambridge and has recently been making claims of a new breakthrough in terms of cystic fibrosis. Their new drug in development, PTI-428, is aimed at helping increasing lung performance in patients.

Unfortunately for Proteostasis, Kerrisdale was not impressed with their figures and the data they released, so Sahm Adrangi decided to do a little more digging into the company. Upon even closer examination of the results of the company, their actual test sample was extremely small. So small in fact, PTI-428 was only tested on four patients. This is not nearly enough to make such claims the company has been making, causing their company stock value to go up.

Kerrisdale took quickly to their report to get it out as soon as possible to inform the public and many investors out there of what is really behind this biotech company, Proteostasis. According to Sahm Adrangi, their drug cocktail is most likely an ineffective drug that works better as a placebo. Unfortunately for Proteostasis, the majority of their company value is invested in their product, which means they will lose more than 70% of their company share value when it comes out that PTI-428 is not effective.

As more companies and investors are becoming aware of the nature of this biotech company, their share values continue to drop and will likely push the company off the map in the near future.

http://www.imdb.com/name/nm1444924/

April 19, 2018

Posted In: Business, Business success, Businessman, CEO, Entrepreneur, Investor

Tags: , , , , , , , , ,

How OSI Group Became a Top 100 Company in the United States

The OSI Group always works hard to give their clients what they need. This is uncommon in food companies and it shows they’re dedicated to all the people they work with. It also shows they are among the best in the industry. Since they know they can do things right, they plan to always give people back the things that will make their business better. For the OSI Group, things have always been better than what they are for other companies. As long as the OSI Group can keep helping people, they feel good about their business. They know success of OSI Group will continue coming their way.

Even when things get difficult for the OSI Group, they know how to push forward. They’ve spent a long time learning about the different options they have and that’s how they plan to keep doing things for others. Even though other companies may not know what they need to do to see the same success as the OSI Group, they can try things on their own. They’ve spent a long time making sure people understand how things will work and how things will change depending on the area they’re in.

While the OSI Group is making news on an international level, they’re still working hard to make sure people know home matters too. They are among the top 100 in the United States. Since they are so dedicated to giving people the chances they need for success, they can keep growing. The growth allows them to produce more. When the company produces more, they give people a chance to try different things. They make a point of showing them how everything will get better and how their business will grow as a result of all the hard work they put into it.

For the OSI Group, the point is making sure they can do things to help others. They spend a lot of time giving everyone the options they need. It is how they work to help businesses. Whether the OSI Group gives small businesses help or large businesses help, they treat them the same way. The OSI Group believes small restaurants need the same kind of attention as big corporations. If they can provide people with this help, they know they’ll make all the right choices. They try to give everyone a chance at bringing attention to the issues on their own without problems in the industry.

Learn More: www.indeed.com/cmp/Osi-Group

April 17, 2018

Posted In: Business, OSI Group

Tags:

What’s Next For Dr. Clay Siegall & Seattle Genetics

Fighting cancer is no easy task. Producing good medications that fights cancer surely isn’t easy as well, but there organizations out there that are willing to put in the time and effort. Seattle Genetics just so happens to be one of those organizations, and it has made an extremely huge impact on this industry. Seattle Genetics was co-founded by Dr. Clay Siegall back in the late 1990s. Dr. Siegall may be one of the most accomplished and well-celebrated professionals in the game. He has a heart of gold as well as a brilliant mind. When it comes to fighting cancer, this dynamic duo has outperformed other duos and here is why.

Antibody-drug conjugates have reshaped cancer research for the better. These advanced drugs are superior, especially when being compared to the predecessors of the past. Dr. Siegall has implemented strong, core principles into this advanced program, and these principles have produced a successful company. Seattle Genetics has a pipeline full of medications, and four out of the 20 medications has great potential to hit the market in future years. ADCETRIS, the company’s top drug, has earned well-over $300 million in a rather short period of time. ADCETRIS is now being used all around the world thanks to Dr. Siegall. By participating in strategic-licensing deals, ADCETRIS has been distributed to the public by many drug companies like Pfizer, Genentech and GlaxoSmithKlien. The company’s growth-trajectory has drastically increased by 46 percent since 2014. In 2016, the company’s sales reached up to $400 million.

Dr. Siegall’s influence on this company can’t be denied, and it can’t be questioned. He is the oil that keeps this engine running, and he is the glue that holds everything together. Seattle Genetics and Dr. Clay Siegall are looking to take this company to the next level via research, innovation and drug development.

April 11, 2018

Posted In: Drug Development

Tempus Technologies of Eric Lefkofky Receives $ 80 Million

The name Eric Lefkofsky is trending because of some noble actions of the great inventor and technology geek. Eric is the CEO of Tempus; a technology outfit that has hit the news for months about its efforts to battle cancer by using cutting-edge technologies. He is also a co-founder of the company and a couple of others in the technology field. Eric is so conspicuous because of his liking for disruptive technologies that help enhance service delivery, especially in the health services sector. Eric also co-founded a NASDAQ-listed company by the name Groupon. The list of the tech companies Eric has helped to start or started on his own is long, but one of the most outstanding because of the contribution it has already made in the fight against cancer is Tempus. It is an operating system that uses personalized patient data to develop profiles and analysis of a patient’s cancer status and trends. Physicians have found the technology handy because it helps them make fast decisions about the cancer patients that they interact with; decisions that are often helpful in battling cancer before the condition spread its ominous tentacles too far. Tempus has already networked with many cancer centers in the US. Now it is getting some money for growth.

Tempus Receives More Donor Funding

According to reports by the Chicago Tribune recently, Mr. Eric Lefkofsky’s Tempus Company has just received a cash boost. It will be yet another gesture of support for the work by the young American inventor and technology enthusiast who uses his passion and skills in technology to promoter cancer treatment and handling. Tempus is noted to be an important resource in promoting upcoming technologies that prove to have the potential to change the old order of things, especially in the medical world. According to the Chicago Tribune report, Tempus has received over $ 80 million from what the news source describes as existing and new investors. So far, Tempus, under the umbrella of Groupon has received up to $210 million since it was started in 2015. Tempus breaks the record of companies that have had the most profound impact on humanity barely two years since they were started. The latest funding is a boost to Mr. Eric Lefkofky’s work in battling the cancer menace through technology. To know more about him click here.

His Contributions to Society

Eric Lefkofsky has demonstrated a heart for helping those who have been afflicted by disease and pain. He and his wife formed the Lefkofsky Family Foundation. The Foundation seeks to extend charity assistance to needy communities and individuals around the globe to resolve or mitigate their health concerns. Eric is a respected personality already. He is a trustee of Lurie Children’s Hospital based in Chicago, the Museum of Science among others.

April 3, 2018

Posted In: Businessman, CEO

Tags:

How Dr. David Samadi Has Revolutioned Prostate Cancer Surgery

The story of how New York-based surgeon Dr. David Samadi became one of the leading robotics experts in his field is a very inspiring one. Like many New Yorkers David Samadi came to the United States from another country. David Samadi grew up in Iran where he lived with his family during the 1970s. However when the political situation in Iran became increasingly unstable and hostile David was forced to leave the country where he was born in order to flee the Iranian Revolution. David Samadi left Iran when he was a teenager and moved to Western Europe where he lived in countries such as the United Kingdom and Belgium.

Despite all of the upheaval in his life of David Samadi was able to somehow focus on his studies.His family would come to settle in the United States after fleeing Iran and David would go on to apply to the State University of New York at Stony Brook. While David was a student at the State University of New York at Stony Brook he he studied biochemistry. David’s passion for medicine would push him to leave the United States and pursue an education in medicine at the Albert Einstein College of Medicine and the Montefiore Medical Center. He would also go on to study the application of robotics to medicine in France. Armed with a thorough education in medicine that he gained from medical institutions around the world David Samadi would go on to become one of the most innovative doctors working in medicine today.

Cancer can be an incredibly difficult disease for medical professionals to treat. Treating cancer requires that doctors be thoughtful about the needs of their patients and that they also be creative with their approach to helping patients heal from this particularly pernicious disease. The disease can be particularly aggressive and as such doctors must also be aggressive in seeking out new ways to combat it. Dr. David Samadi has used his rigorous education to develop new solutions that enhance the treatment that pancreatic cancer patients receive. One of Dr. David Samadi’s claims to fame is the medical breakthrough he achieved when he developed smart robotic prostate surgery. Dr. David Samadi’s new technique essentially allows him to have an enhanced view of the interior of a patient’s body as he is performing surgery. Having an enhanced view of the area that he is operating on has helped him to avoid the kind of nerve damage that often occurs with older surgical techniques used on prostate cancer patients.

March 30, 2018

Posted In: Business success, Doctors

Tags:

Jason Hope and the Important Work of the SENS Foundation

There are few things in life more important than the continued push for research in the field of medicine. Jason Hope, a prominent entrepreneur from Arizona, saw this firsthand as he waded deeper into professional career. Hope is likely most well known for his work within the field of mobile communications, primarily through the company that he founded named JAWA, but he has been working extensively to both broaden his appeal and dig deeper into concepts that are clearly going to be important in the future. For that reason, Jason Hope reached out to the SENS Foundation out of California in order to pledge a massive donation to help the company push forward with more life-changing research.

Before we leap into what Jason Hope is doing with the SENS Foundation, let’s first step back and look at where Hope has come from throughout his career. Jason Hope was born and raised in Arizona, growing up in Tempe. He would go on to attend Arizona State University before scoring his MBA from the WP Carey School of Business. Hope, like many people in his generation, grew up fascinated by technology in all of its various forms and facets Hope wouldn’t wait long in order to jump into his career, employing entrepreneurial skills in order to find early success in mobile communication.

After establishing JAWA, Hope would turn to making partnerships and handing out grants to companies that needed a little bit of a kickstart. This decision would lead Hope to seriously analyze what it means to work alongside individuals in developing their ideas. With this line of thought in his mind, Hope would eventually discover the SENSF foundation — a non-profit organization based out of California that is exclusively focused on pioneering rejuvenating medicine for age-related illness. The SENS Foundation struck a chord with Hope who saw a real future in the field of biotechnology.

Hope wouldn’t let his fascinating for the SENS Foundation fall by the way. Instead, Hope immediately got involved. Jason Hope would meet Dr. Aubrey de Grey, one of the lead medical professionals at the SENS Foundation, and that would lead him to writing a check for $500,000 as a donation. Hope’s donation would be immediately put to use by the SENS Foundation in order to focus on their research in a few key fields. Among these fields, Hope’s donation will be used for fighting Arteriosclerosis. Hope’s work with the SENS Foundation is just getting started.

About Jason Hope: medium.com/@jasonhope 

March 24, 2018

Posted In: Internet of Things, Technology

Tags: